- Home
- SVRE vs SXTP Comparison
SVRE vs SXTP Comparison
Compare SVRE & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVRE
- SXTP
- Stock Information
- Founded
- SVRE 2014
- SXTP 2010
- Country
- SVRE Israel
- SXTP United States
- Employees
- SVRE N/A
- SXTP N/A
- Industry
- SVRE
- SXTP Biotechnology: Pharmaceutical Preparations
- Sector
- SVRE
- SXTP Health Care
- Exchange
- SVRE Nasdaq
- SXTP Nasdaq
- Market Cap
- SVRE 2.6M
- SXTP 3.0M
- IPO Year
- SVRE 2022
- SXTP 2023
- Fundamental
- Price
- SVRE $0.12
- SXTP $0.98
- Analyst Decision
- SVRE
- SXTP Buy
- Analyst Count
- SVRE 0
- SXTP 2
- Target Price
- SVRE N/A
- SXTP $28.80
- AVG Volume (30 Days)
- SVRE 5.3M
- SXTP 98.4K
- Earning Date
- SVRE 08-27-2024
- SXTP 11-18-2024
- Dividend Yield
- SVRE N/A
- SXTP N/A
- EPS Growth
- SVRE N/A
- SXTP N/A
- EPS
- SVRE N/A
- SXTP N/A
- Revenue
- SVRE $458,952.00
- SXTP $441,255.00
- Revenue This Year
- SVRE N/A
- SXTP $267.05
- Revenue Next Year
- SVRE $422.52
- SXTP $181.82
- P/E Ratio
- SVRE N/A
- SXTP N/A
- Revenue Growth
- SVRE N/A
- SXTP 12.07
- 52 Week Low
- SVRE $0.11
- SXTP $0.92
- 52 Week High
- SVRE $1.50
- SXTP $18.36
- Technical
- Relative Strength Index (RSI)
- SVRE 29.85
- SXTP 36.90
- Support Level
- SVRE $0.11
- SXTP $0.92
- Resistance Level
- SVRE $0.13
- SXTP $1.10
- Average True Range (ATR)
- SVRE 0.01
- SXTP 0.11
- MACD
- SVRE 0.00
- SXTP 0.01
- Stochastic Oscillator
- SVRE 24.14
- SXTP 13.79
About SVRE SaverOne 2014 Ltd.
Saverone 2014 Ltd provides driver protection solutions. The company develops and deploys ADAS technologies for transportation safety and driver assistance. The company's product restricts the driver from surfing, communicating, and receiving alerts while driving. The Company has developed a system that provides a solution to the problem of distracted driving caused by cell phone use, which endangers the driver, passengers, other drivers on the road, and pedestrians.
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.